FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
PET brain scan using Vizamyl (flutemetamol F18) with quantification software The FDA has approved an updated label for Vizamyl (flutemetamol...
